Stocks Health care TECX
NASDAQ · Health careTectonic Therapeutic, Inc. (TECX)
It posted a net loss of $88.1M. In fiscal 2025 capital spending exceeded operating cash flow by $60.3M. At September 30, 2026 it held $234.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Tectonic Therapeutic, Inc.
- Net worth
- Tectonic Therapeutic, Inc. has a market value (market cap) of $427.9M at the latest share price, and shareholders' equity of $229.3M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $60.1M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Tectonic Therapeutic, Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
What Tectonic Therapeutic, Inc. does
Tectonic Therapeutic, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker TECX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$74.2M | -$4.05 | -$60.3M |
| 2024 | n/a | -$58M | -$6.83 | -$59.2M |
| 2023 | n/a | -$42.8M | -$33.76 | -$41M |
| 2022 | n/a | -$105.9M | -$2.42 | -$97.5M |
| 2021 | n/a | -$119.1M | -$2.78 | -$100.5M |
| 2020 | n/a | -$119.7M | -$3.31 | -$100M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Tectonic Therapeutic, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- November 5, 2026
- October 29, 2026Passive stake changed SCHEDULE 13G/A
- September 29, 2026Other event 8-K
- August 6, 2026
- August 6, 2026
- June 10, 2026
- May 7, 2026
- May 7, 2026
- April 24, 2026
Insider trades
What the people running Tectonic Therapeutic, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $13.9K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 26, 2026 | Reicin AliseChief Executive Officer, Director | Exercised options | 10,000 | $23.8K |
| September 30, 2026 | McNamara PeterChief Scientific Officer | Soldpre-planned (10b5-1) | 536 | $12.3K |
| September 25, 2026 | Reicin AliseChief Executive Officer, Director | Shares withheld for tax | 1,545 | $36.6K |
| September 25, 2026 | Lochner DanielChief Financial Officer | Shares withheld for tax | 520 | $12.3K |
| September 25, 2026 | Schwabish MarcChief Business Officer | Shares withheld for tax | 411 | $9.7K |
| September 25, 2026 | McNamara PeterChief Scientific Officer | Shares withheld for tax | 444 | $10.5K |
| September 25, 2026 | Ruddy Marcella K.Chief Medical Officer | Shares withheld for tax | 525 | $12.4K |
| August 25, 2026 | McNamara PeterChief Scientific Officer | Exercised options | 43 | $632.5 |
Who owns TECX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Timothy A. Springer13D, may seek influence with 2 related filers | 31.5% | April 7, 2025 |
| Fmr LLC13G, passive with 1 related filers | 15% | May 12, 2025 |
| VV Manager II, LLC13D, may seek influence with 2 related filers | 7% | June 27, 2024 |
| Terrance McGuire13D, may seek influence with 7 related filers | 6.3% | April 7, 2025 |
| Chen Yu13G, passive with 4 related filers | 6.2% | February 27, 2026 |
| Aberdeen Group plc13G, passive with 1 related filers | 6.1% | January 29, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 123 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 2,830,378 | +13,884 |
| TCG Crossover Management, LLC | 1,204,891 | 0 |
| Aberdeen Group plc | 1,141,824 | 0 |
| BlackRock, Inc. | 862,592 | +2,240 |
| First Light Asset Management, LLC | 800,726 | +152,983 |
| Baker Bros. Advisors LP | 607,788 | 0 |
| 5AM Venture Management, LLC | 606,660 | 0 |
| Braidwell LP | 596,900 | -250,251 |
| Vanguard Capital Management LLC | 488,805 | +15,273 |
| Vestal Point Capital, LP | 425,000 | +97,000 |
| Kennedy Capital Management LLC | 282,202 | -4,480 |
| Geode Capital Management, LLC | 270,461 | +2,188 |
| Orbimed Advisors LLC | 226,600 | 0 |
| State Street Corp | 219,908 | +6,403 |
| Ikarian Capital, LLC | 205,837 | +48,300 |
| D. E. Shaw & Co., Inc. | 186,550 | +70,430 |
| Marshall Wace, Llp | 172,101 | -57,494 |
| Millennium Management LLC | 165,525 | +107,177 |
| Squarepoint Ops LLC | 145,028 | -19,391 |
| Ameriprise Financial Inc | 142,448 | -984 |
Insiders
5 insiders reported holding 670,497 shares in total, about $14.7M at the last price.
| Holder | Shares |
|---|---|
| Reicin AliseChief Executive Officer, Director | 446,108127,030 held indirectly |
| Ruddy Marcella K.Chief Medical Officer | 67,157 |
| Lochner DanielChief Financial Officer | 58,024 |
| McNamara PeterChief Scientific Officer | 54,305 |
| Schwabish MarcChief Business Officer | 44,903 |
Questions about TECX
What does Tectonic Therapeutic, Inc. do?
Tectonic Therapeutic, Inc. is a company in the Health care sector, listed on NASDAQ as TECX. Its shares trade on NASDAQ under the ticker TECX.
What is Tectonic Therapeutic, Inc.'s net worth?
Tectonic Therapeutic, Inc. has a market value (market cap) of $427.9M at the latest share price, and shareholders' equity of $229.3M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Tectonic Therapeutic, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $88.1M.
When did Tectonic Therapeutic, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Tectonic Therapeutic, Inc.'s next earnings report?
Tectonic Therapeutic, Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.
Similar companies
Compare TECX with
Follow TECX
Get an email when Tectonic Therapeutic, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Tectonic Therapeutic, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.